Capital Research Global Investors Amgen Inc Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Amgen Inc stock. As of the latest transaction made, Capital Research Global Investors holds 5,670,763 shares of AMGN stock, worth $1.73 Billion. This represents 0.38% of its overall portfolio holdings.

Number of Shares

5,670,763

Previous 6,706,651 15.45%

Holding current value

$1.73 Billion

Previous $1.93 Billion 16.53%

% of portfolio

0.38%

Previous 0.49%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $279 Million - $336 Million	-1,035,888 Reduced 15.45%	5,670,763 $1.61 Billion
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $457 Million - $515 Million	-1,786,558 Reduced 21.04%	6,706,651 $1.93 Billion
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $235 Million - $292 Million	-1,076,582 Reduced 11.25%	8,493,209 $2.28 Billion
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $484 Million - $572 Million	-2,258,318 Reduced 19.09%	9,569,791 $2.12 Billion
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $20.2 Million - $24.6 Million	-89,456 Reduced 0.75%	11,828,109 $2.86 Billion

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $158 Million - $200 Million	-687,700 Reduced 5.46%	11,917,565 $3.13 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $334 Million - $377 Million	-1,490,071 Reduced 10.57%	12,605,265 $2.84 Billion
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $1 Billion - $1.11 Billion	-4,336,215 Reduced 23.53%	14,095,336 $3.43 Billion
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $817 Million - $904 Million	-3,726,355 Reduced 16.82%	18,431,551 $4.46 Billion
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $908 Million - $1.04 Billion	-4,566,275 Reduced 17.09%	22,157,906 $4.98 Billion
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $549 Million - $643 Million	-2,586,436 Reduced 8.82%	26,724,181 $5.68 Billion
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $773 Million - $857 Million	-3,307,947 Reduced 10.14%	29,310,617 $7.14 Billion
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $190 Million - $221 Million	856,237 Added 2.7%	32,618,564 $8.12 Billion
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $376 Million - $448 Million	-1,738,686 Reduced 5.19%	31,762,327 $7.3 Billion
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $32.7 Million - $36.4 Million	139,339 Added 0.42%	33,501,013 $8.51 Billion
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $49.7 Million - $60.9 Million	251,029 Added 0.76%	33,361,674 $7.87 Billion
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $406 Million - $538 Million	-2,226,994 Reduced 6.3%	33,110,645 $6.71 Billion
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $330 Million - $424 Million	1,743,084 Added 5.19%	35,337,639 $8.52 Billion
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $703 Million - $842 Million	4,036,798 Added 13.66%	33,594,555 $6.5 Billion
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $640 Million - $750 Million	-3,836,745 Reduced 11.49%	29,557,757 $5.45 Billion
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $317 Million - $357 Million	-1,750,473 Reduced 4.98%	33,394,502 $6.34 Billion
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $129 Million - $150 Million	722,277 Added 2.1%	35,144,975 $6.84 Billion
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $2.13 Billion - $2.41 Billion	-11,515,778 Reduced 25.07%	34,422,698 $7.14 Billion
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $182 Million - $204 Million	-1,096,159 Reduced 2.33%	45,938,476 $8.48 Billion
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $659 Million - $770 Million	-3,888,105 Reduced 7.64%	47,034,635 $8.02 Billion
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $263 Million - $294 Million	-1,559,732 Reduced 2.97%	50,922,740 $8.86 Billion
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $8.78 Billion - $10 Billion	52,482,472	52,482,472 $9.79 Billion

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Amgen Inc Transaction History